FDA Issues Warning to Merck for Januvia
The Food and Drug Administration has issued a warning to Merck & Co. after the pharmaceutical giant failed to conduct a safety study for its diabetes drug Januvia. According to the Wall Street Journal , the FDA issued the warned to Merck on February 17, informing the pharma company that it was several months late in submitting data about a required safety study.